Marketing-authorisation holder Β· Canada
Emdoka Bvba
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| HALAGON0.5 mg / ml Β· Solution | Halofuginone | Canada | Marketed | 2018 |
| TILCOMED300 mg / ml Β· Solution | Tilmicosin | Canada | Marketed | 2015 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 2 | 2 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.



